Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DZZT | ISIN: US67113Y4052 | Ticker-Symbol: 22SA
Tradegate
25.04.24
14:54 Uhr
0,279 Euro
+0,041
+17,23 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NUWELLIS INC Chart 1 Jahr
5-Tage-Chart
NUWELLIS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2480,25419:53
0,2490,25319:53

Aktuelle News zur NUWELLIS, INC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.04.Nuwellis, Inc. - S-1/A, General form for registration of securities4
09.04.Nuwellis, Inc.: Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health1
26.03.Nuwellis, Inc. - 8-K, Current Report2
13.03.Nuwellis announces public offering of shares and warrants1
13.03.Nuwellis, Inc. - S-1/A, General form for registration of securities-
11.03.Nuwellis, Inc. - 10-K, Annual Report1
07.03.Nuwellis, Inc.: Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference1
06.03.Earnings call: Nuwellis reports growth and strategic initiatives for 20241
06.03.Nuwellis, Inc. - 8-K, Current Report1
05.03.Nuwellis GAAP EPS of -$2.24 misses by $0.85, revenue of $2.6M beats by $0.05M2
05.03.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results96MINNEAPOLIS, March 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...
► Artikel lesen
04.03.Earnings Preview For Nuwellis3
27.02.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 20244
22.02.Nuwellis, Inc.: Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune211MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its distribution...
► Artikel lesen
20.02.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)116MINNEAPOLIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that, effective February 20, 2024, the Company's independent directors approved equity awards under Nuwellis'...
► Artikel lesen
20.02.Nuwellis, Inc.: Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference4
08.02.Nuwellis, Inc. - S-1/A, General form for registration of securities3
06.02.Nuwellis, Inc. - 8-K, Current Report1
06.02.Nuwellis, Inc.: New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload250MINNEAPOLIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the publication...
► Artikel lesen
31.01.Nuwellis, Inc. - S-1/A, General form for registration of securities4
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1